![Daniele Scarinci](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniele Scarinci
Fondatore presso Xgen Venture Sgr SpA
Profilo
Before co-founding XGEN in 2021, Daniele was Investment Director in Genextra since 2006.
Daniele is Chairman of Tethis, where he served as CEO between 2020 and 2022, and board member of Kuste Biopharma and Page Therapeutics.
Prior to Genextra, Daniele held several strategic and financial planning collaborations in different sectors (retail, tlc, media, tech etc), and business planning & investor relations in e.Biscom/Fastweb.
Daniele holds a cum laude degree in in Economics of Financial Markets, Rome University of Tor Vergata.
Posizioni attive di Daniele Scarinci
Società | Posizione | Inizio |
---|---|---|
Tethis SpA
![]() Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Presidente | 20/10/2022 |
Kuste Biopharma SAS
![]() Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Direttore/Membro del Consiglio | - |
Xgen Venture Sgr SpA
![]() Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Fondatore | 01/06/2021 |
Precedenti posizioni note di Daniele Scarinci
Società | Posizione | Fine |
---|---|---|
Genextra SpA
![]() Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investitore di Private Equity | 01/09/2022 |
InnovHeart Srl
![]() InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Direttore/Membro del Consiglio | 01/01/2020 |
Formazione di Daniele Scarinci
Università degli Studi di Roma Tor Vergata | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Tethis SpA
![]() Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Health Technology |
Genextra SpA
![]() Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Finance |
Kuste Biopharma SAS
![]() Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Health Technology |
Xgen Venture Sgr SpA
![]() Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |
InnovHeart Srl
![]() InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Health Technology |
- Borsa valori
- Insiders
- Daniele Scarinci